Friday, September 17, 2021
Home Latest News MODERNA VACCINE SHOWS POSITIVE RESULTS

MODERNA VACCINE SHOWS POSITIVE RESULTS

Moderna has been the first to start human testing of a vaccine for the novel coronavirus on March 16, 66 days after the genetic sequence of the virus was released. And if medical experts are to be believed the first and second stage trials of the vaccine has shown encouraging results.

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, whose researchers developed Moderna’s vaccine candidate, called the results “good news,” noting that the study found no serious adverse events and the vaccine produced “reasonably high” levels of virus-killing or neutralizing antibodies.

“If your vaccine can induce a response comparable with natural infection, that’s a winner,” Fauci said in a telephone interview. “That’s why we’re very pleased by the results.”

No study volunteers experienced a serious side effect, but more than half reported mild or moderate reactions such as fatigue, headache, chills, muscle aches or pain at the injection site. These were more likely to occur after the second dose and in people who got the highest dose.

The US government is supporting Moderna’s vaccine with nearly half a billion dollars and has chosen it as one of the first to enter large-scale human trials. A successful vaccine could be a turning point for Cambridge, Massachusetts-based Moderna, which has never had a licensed product.

Moderna’s shot, mRNA-1273, uses ribonucleic acid (RNA) – a chemical messenger that contains instructions for making proteins. When injected into people, the vaccine instructs cells to make proteins that mimic the outer surface of the coronavirus, which the body recognises as a foreign invader, and mounts an immune response against it.

The results released on Tuesday involved three doses of the vaccine, tested in groups of 15 volunteers aged 18 to 55 who got two shots, 28 days apart. The groups tested 25, 100 or 250 micrograms of the vaccine.

Adverse events after the second dose occurred in seven of the 13 volunteers who got the 25-microgram dose, all 15 participants who received the 100 microgram dose and all 14 who got the 250 microgram dose. In the highest-dose group, three patients had severe reactions such as fever, chills, headache or nausea. One of these had a fever of 103.28 Fahrenheit (39.6 C).

“It’s a good first step,” said Dr William Schaffner, a vaccine expert at Vanderbilt University Medical Center who was not involved in the study. “There’s nothing here that would inhibit one from going ahead to the Phase 2/Phase 3 trials,” he said.

In April, Moderna expanded the Phase 1 trial to include adults over 55, who are more at risk of serious disease, with the aim of enrolling 120 volunteers. Moderna said it will follow study volunteers for a year to look for side effects and check how long immunity lasts. Moderna started its phase 2 trial in May and expects to start a phase 3 trial on July 27.

Phase 1 trials aim to ensure a treatment is safe and help determine an effective dose. Phase 2 trials test a treatment in a larger group and get an early read on effectiveness. Phase 3 trials are conducted in a large group of individuals to confirm efficacy and identify rare side effects. Moderna’s Phase 3 trial will be conducted in 30,000 volunteers.



Most Popular

After New Zealand, England’s upcoming tour of Pakistan comes under threat

Pakistan's upcoming series against England has also come under threat after New Zealand abandoned the Pakistan tour just 5 minutes before the...

Main Bhi Barbaad: Hina Khan, Angad Bedi set to win hearts again with new music video, details inside

Popular TV actor Hina Khan is all set to drop her much-awaited music video song Main Bhi Barbaad on September 13 this...

India sets new record, over 2 crore vaccinations on PM Modi’s birthday

India set a new record on Friday by vaccinations of over 2 crore COVID-19 vaccines. As per Cowin portal, till 5:40 pm,...

Pakistan fans, cricketers disappointed over New Zealand’s last-minute decision to cancel tour

The announcement caused shock among the cricket fraternity following hours of speculation over the fate of the series. Several Pakistan players expressed their disappointment at Kiwi's last-minute decision. New Zealand were scheduled to play 3 ODI and 5 T20Is in Pakistan.